# Efficacy of Lipid-Lowering Therapy Based on Apolipoprotein B Versus LDL-Cholesterol Levels in Patients Undergoing Percutaneous Coronary Intervention

> **NCT06626126** · NA · NOT_YET_RECRUITING · sponsor: **University Medical Center Ho Chi Minh City (UMC)** · enrollment: 1448 (estimated)

## Conditions studied

- Coronary Arterial Disease (CAD)
- Percutaneous Coronary Intervention
- LDL-cholesterol
- Lipid Metabolism Disorders

## Interventions

- **OTHER:** ApoB-guided-LLT
- **OTHER:** LDL-C-guided-LLT

## Key facts

- **NCT ID:** NCT06626126
- **Lead sponsor:** University Medical Center Ho Chi Minh City (UMC)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2028-01-01
- **Final completion:** 2029-01-01
- **Target enrollment:** 1448 (ESTIMATED)
- **Last updated:** 2024-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06626126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06626126, "Efficacy of Lipid-Lowering Therapy Based on Apolipoprotein B Versus LDL-Cholesterol Levels in Patients Undergoing Percutaneous Coronary Intervention". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06626126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*